Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Clinical Research
9 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Funding
Elligo Health Research Raises $20M to Connect More Physicians and Their Patients to Clinical Research as a Care Option
PR-M05-19-NI-033
Data
Allergan Presents Data From Seven Abstracts At The 2019 American Academy of Dermatology (AAD) in Washington D.C.
PR-M03-19-NI-004
Clinical Trials
Phase III Study Results for Peanut Allergy Therapy Are a Mixed Bag
PAO-M11-18-NI-021
Clinical Study
Allergan Launches Personalized Study Approach for Clinical Research Programs in Inflammatory Bowel Disease
PR-M10-18-NI-024
Clinical Results
Fish-Oil Drug Shows Dramatic Results in Cardiovascular Study
PAO-M09-18-NI-025
Clinical Research
Eating Well Might Improve Cancer Treatments
PAO-M07-18-NI-006
Biosimilars
Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®
PR-M01-18-NI-092
Clinical Research
Castle Creek Pharmaceuticals Announces Data Validating First Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex Clinical Research
PR-M01-18-NI-065
Clinical Research
CRO Pharmaceutical Product Development Wins NIH Contract for HIV Research
PAO-M11-17-NI-021
